Anika Therapeutics, Inc.
2013 Q4 - 2025 Q4 (27 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/17/2026 | 7 | 0.0% | 766 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 9 | 0.0% | 980 | 9/30/2025 |
| 2025 Q2 | 8/14/2025 | 10 | 0.0% | 979 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 15 | 0.0% | 979 | 3/31/2025 |
| 2024 Q4 | 3/18/2025 | 16 | 0.0% | 979 | 12/31/2024 |
| 2024 Q3 | 4/4/2025 | 24 | 0.0% | 979 | 9/30/2024 |
| 2024 Q2 | 4/8/2025 | 27 | 0.0% | 1,061 | 6/30/2024 |
| 2024 Q1 | 5/16/2024 | 37 | 0.0% | 1,472 | 3/31/2024 |
| 2023 Q4 | 2/13/2024 | 55 | 0.0% | 2,409 | 12/31/2023 |
| 2023 Q3 | 11/14/2023 | 303 | 0.0% | 16,282 | 9/30/2023 |
| 2023 Q2 | 8/21/2023 | 461 | 0.0% | 17,740 | 6/30/2023 |
| 2023 Q1 | 5/9/2023 | 524 | 0.0% | 18,254 | 3/31/2023 |
| 2022 Q4 | 2/14/2023 | 547 | 0.0% | 18,488 | 12/31/2022 |
| 2022 Q3 | 11/21/2022 | 435 | 0.0% | 18,269 | 9/30/2022 |
| 2022 Q2 | 8/15/2022 | 413 | 0.0% | 18,501 | 6/30/2022 |
| 2022 Q1 | 5/16/2022 | 468 | 0.0% | 18,637 | 3/31/2022 |
| 2021 Q4 | 2/15/2022 | 716 | 0.0% | 19,970 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 830 | 0.0% | 19,493 | 9/30/2021 |
| 2021 Q2 | 8/16/2021 | 863 | 0.0% | 19,937 | 6/30/2021 |
| 2021 Q1 | 5/18/2021 | 856 | 0.0% | 20,974 | 3/31/2021 |
| 2020 Q4 | 2/16/2021 | 949 | 0.0% | 20,974 | 12/31/2020 |
| 2020 Q3 | 11/17/2020 | 742 | 0.0% | 20,974 | 9/30/2020 |
| 2020 Q2 | 8/17/2020 | 783 | 0.0% | 20,740 | 6/30/2020 |
| 2020 Q1 | 5/13/2020 | 583 | 0.0% | 20,150 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 1,061 | 0.0% | 20,457 | 12/31/2019 |
| 2014 Q1 | 5/8/2014 | 893 | 0.0% | 21,735 | 3/31/2014 |
| 2013 Q4 | 2/10/2014 | 829 | 0.0% | 21,735 | 12/31/2013 |